Short Interest in Oxford Biomedica plc (OTCMKTS:OXBDF) Rises By 131.0%

Oxford Biomedica plc (OTCMKTS:OXBDF) was the target of a large increase in short interest in February. As of February 28th, there was short interest totalling 78,300 shares, an increase of 131.0% from the February 13th total of 33,900 shares. Based on an average trading volume of 4,600 shares, the short-interest ratio is currently 17.0 days. Approximately 0.1% of the company’s stock are sold short.

Oxford Biomedica Price Performance

Oxford Biomedica stock opened at $3.53 on Friday. The company’s fifty day simple moving average is $4.79 and its 200-day simple moving average is $4.97. The company has a debt-to-equity ratio of 1.48, a quick ratio of 2.07 and a current ratio of 2.35. Oxford Biomedica has a 12 month low of $2.40 and a 12 month high of $5.68.

Oxford Biomedica Company Profile

Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems.